FDA Inspection 888026 — Bergenstal, Richard M., M.D., Clinical Investigator
The FDA completed an inspection of Bergenstal, Richard M., M.D., Clinical Investigator on Aug 1, 2014 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 1, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Minneapolis, MN (United States)
Additional Details
Clinical Investigator (CI)